Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group
Management of physical activity intolerance in GSD V and GSD VII is nuanced and impacts activities of daily living (ADL). Guidelines support clinicians in multiple disciplines across the continuum of care and lifespan of patients. Overview of management, including guidance on physical activity, nutr...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Universidad Europea (UEM) |
| Repositorio: | ABACUS. Repositorio de Producción Científica |
| Idioma: | inglés |
| OAI Identifier: | oai:abacus.universidadeuropea.com:11268/11047 |
| Acceso en línea: | http://hdl.handle.net/11268/11047 |
| Access Level: | acceso abierto |
| Palabra clave: | Enfermedad del almacenamiento de glucógeno tipo V Genética Enfermedad cardiovascular Biología molecular |
| Sumario: | Management of physical activity intolerance in GSD V and GSD VII is nuanced and impacts activities of daily living (ADL). Guidelines support clinicians in multiple disciplines across the continuum of care and lifespan of patients. Overview of management, including guidance on physical activity, nutrition, pain, medical emergencies, and rehabilitation. Considerations for general medical care, including established and emerging concomitant conditions, potential drug-disease interactions, surgery, and obstetrics. Emerging issues and knowledge gaps are highlighted. |
|---|